Who Paid My Doc
A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older
ClinicalTrials.gov NCT05566639
Research payments
$99,151,829
Through program year 2024, $99,151,829 in research payments was reported against A Phase 3, Randomized, Observer-blind, Active-controlled Study to Evaluate the Safety and Efficacy of mRNA-1010 Candidate Seasonal Influenza Vaccine in Adults 50 Years and Older, across 130,962 payments, paid by Moderna TX, Inc..
- Paid by
- Moderna TX, Inc.
- ClinicalTrials.gov
- NCT05566639
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $16,266,455 | 815 |
| 2023 | Research | $82,885,374 | 130,147 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ronald Surowitz Jupiter, FL Named on 5,578 payments
- John Beckes Alpine, CA Named on 3,354 payments
- Margaret Rhee Akron, OH Named on 3,197 payments
- Manuchehr Darani Newport Beach, CA Named on 3,008 payments
- Keila Hoover Miami, FL Named on 2,997 payments
- Jon Finley Stockbridge, GA Named on 2,662 payments
- Hessam Aazami Canoga Park, CA Named on 2,609 payments
- Mark Turner Meridian, ID Named on 2,512 payments
- Sheila Sanchez Mayaguez, PR Named on 2,449 payments
- Carlos Sesin Coral Gables, FL Named on 2,402 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.